Go back to the public home page
Hello .
 U.S. 


  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

related announcements

News

  • Karuna Therapeutics Inc.

    Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2[...]

  • Karuna Therapeutics Inc.

    Karuna Therapeutics Reports Second Quarter 2022 Financial Results and[...]

  • Holly Energy Partners LP

    Holly Energy Partners, L.P. Reports Second Quarter Results

More

Company News

  • Blue Apron Holdings Inc.

    Blue Apron Holdings, Inc. Reports Second Quarter 2022 Results

  • Kodiak Sciences Inc.

    Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3[...]

  • Elanco Animal Health Inc.

    Elanco Animal Health Reports Second Quarter 2022 Results

More

BMW - Bayerische Motoren Werke AG

05/24/2022 | Press release | Distributed by Public on 05/23/2022 16:05

50 Jahre BMW M: Die Editionsmodelle des BMW M3 und des BMW M4 zum Jubiläum.

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website.

Close

Smartlinks | BMW - Bayerische Motoren Werke AG | News | Company News | Business Announcement | Products and Services | Manufacturing | Automotive | Public Companies | Automotive Companies | Borsa Italiana | London Stock Exchange (LSE) | Börse Frankfurt | Six Swiss Exchange | Wiener Börse (ATX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | Budapest Stock Exchange | Bursa de Valori Bucuresti (BVB) | OTC Markets | BX Swiss | Tradegate Exchange | XETRA | Turquoise | Börse Hamburg | Börse Hannover | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Börse Berlin Equiduct Trading | Aquis Exchange | SIGMA X MTF | EuroTLX | Bolsa Institucional de Valores (BIVA) | Euronext Block MTF

 Back

Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact